Britta Will

5.4k total citations · 2 hit papers
61 papers, 2.7k citations indexed

About

Britta Will is a scholar working on Hematology, Molecular Biology and Genetics. According to data from OpenAlex, Britta Will has authored 61 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 44 papers in Hematology, 26 papers in Molecular Biology and 19 papers in Genetics. Recurrent topics in Britta Will's work include Acute Myeloid Leukemia Research (30 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (12 papers) and Platelet Disorders and Treatments (11 papers). Britta Will is often cited by papers focused on Acute Myeloid Leukemia Research (30 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (12 papers) and Platelet Disorders and Treatments (11 papers). Britta Will collaborates with scholars based in United States, Germany and United Kingdom. Britta Will's co-authors include Ulrich Steidl, Amit Verma, Boris Bartholdy, Tihomira I. Todorova, Laura Barreyro, Dirk Loeffler, Claus Nerlov, Antonio Díaz, Timm Schroeder and Ranjani Lakshminarasimhan and has published in prestigious journals such as Nature, Science and Proceedings of the National Academy of Sciences.

In The Last Decade

Britta Will

59 papers receiving 2.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Chronic interleukin-1 exposure drives haematopoietic stem cells towards precocious myeloid differentiation at the expense of self-renewal

2016 500 citations Eric M. Pietras, Sarah Fong et al. Nature Cell Biology profile →
Chaperone-mediated autophagy sustains haematopoietic stem-cell function

2021 192 citations Shuxian Dong, Qian Wang et al. Nature profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Britta Will United States	28	1.3k	1.2k	681	517	296	61	2.7k
Johanna Flach Germany	16	1.2k 1.0×	1.5k 1.2×	681 1.0×	543 1.1×	489 1.7×	31	2.8k
Ayako Nakamura‐Ishizu Japan	21	946 0.7×	1.0k 0.9×	538 0.8×	385 0.7×	118 0.4×	43	2.1k
Isabel Beerman United States	21	1.1k 0.9×	1.6k 1.4×	967 1.4×	408 0.8×	152 0.5×	45	3.1k
Borja Sáez United States	22	772 0.6×	1.7k 1.4×	492 0.7×	423 0.8×	175 0.6×	41	2.8k
Maria Carolina Florian Germany	21	978 0.8×	1.2k 1.0×	703 1.0×	313 0.6×	92 0.3×	45	2.3k
Fabı́ola Traina Brazil	28	1.3k 1.0×	1.2k 1.0×	369 0.5×	909 1.8×	96 0.3×	160	2.6k
Kentaro Hosokawa Japan	17	1.7k 1.3×	1.8k 1.5×	888 1.3×	761 1.5×	172 0.6×	28	3.7k
Mary Mohrin United States	9	600 0.5×	1.3k 1.1×	357 0.5×	199 0.4×	286 1.0×	11	2.1k
Dana E. Cullen United States	11	751 0.6×	1.5k 1.3×	320 0.5×	465 0.9×	94 0.3×	15	2.2k
Hai T. Ngo United States	25	713 0.6×	1.3k 1.1×	379 0.6×	544 1.1×	82 0.3×	72	2.2k

Countries citing papers authored by Britta Will

Since Specialization

Citations

This map shows the geographic impact of Britta Will's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Britta Will with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Britta Will more than expected).

Fields of papers citing papers by Britta Will

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Britta Will. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Britta Will. The network helps show where Britta Will may publish in the future.

Co-authorship network of co-authors of Britta Will

This figure shows the co-authorship network connecting the top 25 collaborators of Britta Will. A scholar is included among the top collaborators of Britta Will based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Britta Will. Britta Will is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wang, Hao, R. Alejandro Sica, Gurbakhash Kaur, et al.. (2024). TMIGD2 is an orchestrator and therapeutic target on human acute myeloid leukemia stem cells. Nature Communications. 15(1). 11–11. 32 indexed citations

Kao, Yun-Ruei, Jiahao Chen, Rajni Kumari, et al.. (2024). An iron rheostat controls hematopoietic stem cell fate. Cell stem cell. 31(3). 378–397.e12. 16 indexed citations

Ek, Fredrik, Agatheeswaran Subramaniam, Yun-Ruei Kao, et al.. (2023). Ciclopirox ethanolamine preserves the immature state of human HSCs by mediating intracellular iron content. Blood Advances. 7(24). 7407–7417. 2 indexed citations

Okoye-Okafor, Ujunwa Cynthia, Komal Kumar Javarappa, Joseph Saad, et al.. (2022). Megakaryopoiesis impairment through acute innate immune signaling activation by azacitidine. The Journal of Experimental Medicine. 219(11). 1 indexed citations

Bartholdy, Boris, Kith Pradhan, Tushar D. Bhagat, et al.. (2022). PU.1-Dependent Enhancer Inhibition Separates Tet2 -Deficient Hematopoiesis from Malignant Transformation. Blood Cancer Discovery. 3(5). 444–467. 11 indexed citations

Dong, Shuxian, Qian Wang, Antonio Díaz, et al.. (2021). Chaperone-mediated autophagy sustains haematopoietic stem-cell function. Nature. 591(7848). 117–123. 192 indexed citations breakdown →

Kirchner, Philipp, Mathieu Bourdenx, Julio Madrigal‐Matute, et al.. (2019). Proteome-wide analysis of chaperone-mediated autophagy targeting motifs. PLoS Biology. 17(5). e3000301–e3000301. 162 indexed citations

Santini, Valeria, David Valcárcel, Uwe Platzbecker, et al.. (2019). Phase II Study of the ALK5 Inhibitor Galunisertib in Very Low-, Low-, and Intermediate-Risk Myelodysplastic Syndromes. Clinical Cancer Research. 25(23). 6976–6985. 60 indexed citations

Cusan, Monica, Sheng F. Cai, Helai P. Mohammad, et al.. (2018). LSD1 inhibition exerts its antileukemic effect by recommissioning PU.1- and C/EBPα-dependent enhancers in AML. Blood. 131(15). 1730–1742. 81 indexed citations

10.

Chen, Jiahao, Daqian Sun, Tihomira I. Todorova, et al.. (2018). Myelodysplastic syndrome progression to acute myeloid leukemia at the stem cell level. Nature Medicine. 25(1). 103–110. 149 indexed citations

11.

Bartholdy, Boris, Kelly Mitchell, Wendy M. McKimpson, et al.. (2017). A myeloid tumor suppressor role for NOL3. The Journal of Experimental Medicine. 214(3). 753–771. 11 indexed citations

12.

Benard, Lumie, Luis A. Carvajal, Amit Verma, et al.. (2017). Pre-Clinical Modeling of Concomitant Therapy with Azacytidine and Eltrombopag in MDS/AML. Blood. 130. 2950. 3 indexed citations

13.

Pietras, Eric M., Sarah Fong, Dirk Loeffler, et al.. (2016). Chronic interleukin-1 exposure drives haematopoietic stem cells towards precocious myeloid differentiation at the expense of self-renewal. Nature Cell Biology. 18(6). 607–618. 500 indexed citations breakdown →

14.

Schinke, Carolina, Orsi Giricz, Weijuan Li, et al.. (2015). IL8-CXCR2 pathway inhibition as a therapeutic strategy against MDS and AML stem cells. Blood. 125(20). 3144–3152. 145 indexed citations

15.

Bartholdy, Boris, Maximilian Christopeit, Britta Will, et al.. (2014). HSC commitment–associated epigenetic signature is prognostic in acute myeloid leukemia. Journal of Clinical Investigation. 124(3). 1158–1167. 32 indexed citations

16.

Will, Britta, Tihomira I. Todorova, Amit Verma, Ulrich Steidl, & Ari Melnick. (2014). Regulation of hematopoietic stem cell fate by special at-rich sequence binding protein 1. Experimental Hematology. 42(8). S66–S66. 1 indexed citations

17.

Elias, Harold K., Carolina Schinke, Sanchari Bhattacharyya, et al.. (2013). Stem cell origin of myelodysplastic syndromes. Oncogene. 33(44). 5139–5150. 30 indexed citations

18.

Nischal, Sangeeta, Sanchari Bhattacharyya, Maximilian Christopeit, et al.. (2012). Methylome Profiling Reveals Distinct Alterations in Phenotypic and Mutational Subgroups of Myeloproliferative Neoplasms. Cancer Research. 73(3). 1076–1085. 42 indexed citations

19.

Will, Britta, Masahiro Kawahara, Ingmar Bruns, et al.. (2009). Effect of the nonpeptide thrombopoietin receptor agonist Eltrombopag on bone marrow cells from patients with acute myeloid leukemia and myelodysplastic syndrome. Blood. 114(18). 3899–3908. 95 indexed citations

20.

Ebralidze, Alexander K., Florence C. Guibal, Ulrich Steidl, et al.. (2008). PU.1 expression is modulated by the balance of functional sense and antisense RNAs regulated by a shared cis-regulatory element. Genes & Development. 22(15). 2085–2092. 144 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact